The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if sequence inversion of Intensity - modulated
Radiotherapy (IMRT) for prostate cancer, can improve the safety and deliverability of
concurrent docetaxel chemotherapy with long - term hormonal therapy. The hypothesis is that
inverting the traditional sequence of radiotherapy can delay the time to treatment - induced
bowel toxicity.